Vivid Genomics

Using AI, genomics, and dementia biology to develop non-invasive tests. Helping pharma companies identify patient variation in clinical trials.

[Eisai US @EisaiUS]

NEW DATA: Topline data from the confirmatory Phase 3 CLARITY AD trial is now available for our investigational anti-amyloid-beta protofibril antibody. #Alzheimersdisease

[Haiyang Zhang @HaiyangZhang7]

Check out our amazing poster in #AAIC21 We use genetics and machine learning to predict Alzheimer's Disease progression rate! #VividGenomics @VGenomics

[Vivid Genomics @VGenomics]

The landmark approval of @Biogen’s Aduhelm intensifies the need for early detection and screening in Alzheimer’s disease, and highlights the importance of stratification in clinical trials. Vivid Genomics is addressing both of these issues.

[Alzheimer's Drug Discovery Foundation @TheADDF]

Today the #FDA advisory committee will meet to vote on #aducanumab, which if approved, will be the first disease-modifying #Alzheimers drug. @a_hfillit spoke with @MMarchioneAP to weigh in on this decision, which holds big implications for the community: https://t.co/abafvwqnwm

[Vivid Genomics @VGenomics]

We're presenting this week at @CTADconference virtual poster hall. Rate of decline affects trials in both pre-screen trial populations and among enrolled individuals; broad genetics improves prediction in both. Posters LP13 & P65 from Nov 4-7 at 1pm ET.
#CTAD2020 #ENDALZ

[Vivid Genomics @VGenomics]

When #dementia clinical trials have placebo arms that do not decline, it's hard to see a drug effect. Join us at the #ISCTM2020 poster session tomorrow at 11:50am PT as we present the value of genome wide variants beyond APOE to improve predictive models of cognitive decline.

[Dr. Jay Electronica @inthosegenespod]

Hey fam! I'm Dr. Janina Jeff, a human population "Geneti-SIS" who also hosts a dope ass podcast called In Those Genes! Our show uses Black culture and hip hop as a vessel to teach genetics to the Black community
#BlackInGenetics
#BlackInGeneticsRollCall
https://t.co/NXjqaA9vgx

[Vivid Genomics @VGenomics]

Our founder & CEO Julie Collens was featured on the @TacosandTechPod with @NealBloom! Tune in to hear about what brought her to San Diego, her early career, and her entrepreneurial journey. 🌮 https://t.co/eUIGQt5OzJ

[Vivid Genomics @VGenomics]

@medcitynews Thanks for the opportunity!

[Vivid Genomics @VGenomics]

We're excited to have been selected again as one of San Diego's "Cool Companies"! @sdvg

[Vivid Genomics @VGenomics]

Please be safe and take care of each other. Science and humanity will get us through.

[Abraham Palmer @AbePalmer]

You are going to remember how you reacted to this crisis for the rest of your life, so try to give yourself a good story to tell.

Be compassionate.
Take care of your family.
Work for the greater good.
Don’t do anything you will later regret.

Your future self will thank you.

[Vivid Genomics @VGenomics]

Pre-symptomatic studies in #Alzheimer's will be more and more common, and screening eligible patients will continue to be a challenge. #Precisionmedicine is a more targeted, promising approach.
https://t.co/RbB6lYZO8B

[Tony Hawk @tonyhawk]

My mom died peacefully this afternoon after a decade-long battle with Alzheimer’s / Dementia. Instead of dwelling on the disease that took her away, I would rather acknowledge the successes in her life (see screenshot)
And please support @Hilar4Charity and/or @alzassociation

[Vivid Genomics @VGenomics]

Great to see budget increases to @NIH funding to support research, biomarker development, and drug development for #Alzheimer's. 6x increase in funding since the National Alzheimer's Project Act was signed in 2011. #ENDALZ
https://t.co/guImoZwqqC

[Vivid Genomics @VGenomics]

Very cool to have our CEO, Julie Collens, present at @TEDxSanDiego this past weekend on why #Alzheimer's drug development is so hard, the potential for #PrecisionMedicine, and the importance of taking up hard challenges. #TEDx

[Eric Green @NHGRI_Director]

How big is the human genome? We barely fit 1/1000 of the human genome sequence typed out on a hallway wall near my office @genome_gov! Take a look at the video and see what I mean...

[Vivid Genomics @VGenomics]

Round table on sex/gender consideration in #Alzheimer's clinical trials at #CTAD2019 - Dr. Rachelle Doody "among the challenges are that in certain parts of the world women are not allowed to provide consent" @womensbrainpro

[Vivid Genomics @VGenomics]

On future of #Alzheimer's drug development - Dr. Paul Aisen “amyloid not the only proteinopathy, and other pathologies beyond tauopathy increase as the disease progresses, including alpha-synuclein and TDP-43 and we need to address multiple proteinopathies”
@ATRI_USC #CTAD2019

[Vivid Genomics @VGenomics]

Dr. Eliezar Masliah from the ⁦#NIA on future of #Alzheimer’s disease and related dementia trials -#PrecisionsionMedicine is the goal. #CTAD2019

[Vivid Genomics @VGenomics]

67% of trial APOE4+, 42% APOE4+ individuals in high dose group experienced ARIA-E = 27%. Is it possible to identify those who will experience ARIA-E among APOE4+ individuals? Identifying heterogeneity could be helpful in reducing adverse events. @biogen #CTAD2019